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The cysteine residue at position 148 in the lactose carrier protein of Escherichia coli has been replaced by 
serine using oligonucleotide-directed, site-specific mutagenesis of the lacy gene. The mutant carrier is incor- 
porated into the cytoplasmic membrane to the same extent as the wild-type carrier, confers a lactose-positive 
phenotype on cells, and actively transports lactose and other galactosides. However, the maximum rate of 
transport for several substrates is reduced by a factor of 6-10 while the apparent affinity is reduced by a 
factor of 2-4. Carrier activity in the mutant is much less sensitive to sulfhydryl reagents (HgCl,, p-(chloro- 
mercuri)benzenesulfonate and N-ethylmaleimide) than in the wild type, and P-D-galactosyl I-thio-,9-D- 
galactoside does not protect the mutant carrier against slow inactivation by Wethylmaleimide. It is con- 
cluded that the Cysi4* residue is not essential for carrier-catalyzed galactoside: proton symport and that 
its alkylation presumbly prohibits access of the substrate to the binding site by steric hindrance. A serine 
residue at position 148 in the amino acid sequence appears to alter the protein structure in such a way that 
one or more sullhydryl groups elsewhere in the protein become accessible to alkylating agents thereby inhib- 
iting transport. Recently, Trumble et al. [(1984) Biochem. Biophys. Res. Commun. 119, 860-8671 arrived 
at similar conclusions by investigating a mutant carrier with a Cysi4* --t Glyia replacement. 
Lactose carrier Site-directed mutagenesis 
1. INTRODUCTION 
In their classic experiments, Fox and Kennedy 
[l] identified the lactose: Hi carrier as an integral 
protein of the cytoplasmic membrane of Es&e- 
richia coli by differential labeling of a sulfhydryl 
group by N-ethylmaleimide (see [2-51 for recent 
reviews on the structure and function of this pro- 
tein). This critical sulfhydryl group was assigned to 
the cysteine residue 148 in the amino acid sequence 
[6]. Because modification of this thioi abolishes 
substrate binding [7-91, Cysr4’ is considered to be 
at or near the sugar binding site. Studies on the ef- 
Abbreviations: GalSGal, ,&D-galactosyl I-thio-,&D- 
galactoside; NpcuGal, p-nitrophenyl~-g~actoside; 
MeSGai, methyl I-thio+D-galactoside; NpflGal, o-ni- 
trophenyl-B-D-galactoside 
Galactoside transport Sui&dryI reagent 
feet of collisional quenchers on carrier-bound 
dansyl-galactosides or carrier alkylated at CYS’~~ 
by N-(1-pyrenyl)maleimide suggest hat the bind- 
ing site is buried within the protein and not on the 
surface and that the cysteine residue is located at a 
position corresponding to the depth of C-atom 5 of 
the phospholipid acyl chains [lo]. However, it re- 
mains unknown whether this thiol is essential for 
substrate recognition at the single binding site in 
the protein or whether its modification prohibits 
access of the substrate by steric hindrance. Ex- 
change of amino acids via site-directed mutagene- 
sis of the cloned and sequenced lacy gene [ 11,121 
coding for the carrier protein can distinguish be- 
tween these alternatives. This communication de- 
scribes the properties of a mutant lactose carrier in 
which CYS’~~ is replaced by a serine residue. While 
this work was in progress, Trumble et al. [ 131 using 
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the same approach reported experiments with a 
mutant carrier with a Cy~‘~~-+Gly~~’ substitu- 
tion. Both studies come to the conclusion that the 
thiol at Cys14’ is not essential for substrate recogni- 
tion or galactoside : H+ symport. 
2. MATERIALS AND METHODS 
Oligonucleotide synthesis was carried out as 
described [14,15]. Cells were grown and induced 
with isopropyl-fl-D-thiogalactoside (0.2 mM for 
strains carrying the mutated lacy gene, 0.1 mM 
for lacy+ cells) as detailed in [l 11. Cells were 
treated with EDTA (1 mM) for 2 min in 0.2 M 
Tris, pH 8.0, at 25°C before the transport meas- 
urements [9]. Uptake was terminated by addition 
of 0.15 M LiCl plus 2 mM HgC12. Carrier levels in 
membranes were quantitated by substrate binding 
[9,16] or by an immunological method [ 171. 
3. RESULTS 
3.1. Oligonucleotide-directed site-specific muta- 
genesis 
The strategy for changing codon 148 in the lacy 
gene is outlined in fig.1. The 2.3 kb lacy-contain- 
ing fragment of plasmid pGM21 [l l] was ligated 
into the single EcoRI site of the vector pEMBLS( + ) 
[18] yielding plasmid pTJN2. Upon superinfection 
of a strain carrying this plasmid with phage IRl, 
single strands of the plasmid pTJN2 containing the 
sense strand of the insert are packaged into viral 
particles. Single-stranded plasmid pTJN2 was an- 
nealed to a 19-merit oligodesoxyribonucleotide 
with the indicated mismatches in codons 147 and 
148. The mutant gene having these base changes 
codes for Gly147-Ser’48. Furthermore, a new re- 
cognition site for the restriction enzyme X/z011 
(recognition sequence PulGATCPy) is created 
which simplifies the identification of mutant 
clones. As described in the legend to fig.1, a clone 
having the expected properties was found. The 
mutated gene was re-inserted into the vector 
pACYC184 yielding plasmid pJAS3. pJAS3 codes 
for a serine residue at codon 148 of the lacy gene, 
carries a conservative base substitution in codon 
147, but is otherwise identical to the previously 
described lacy+-containing plasmid pGM21 [ 111. 
The properties of the mutant and wild-type carrier 
are compared in a Lac Z’Y- @3-galactosidase posi- 
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Fig. 1. Localized mutagenesis of the lacy gene. The 
2320 bp-EcoRI restriction fragment of plasmid pGM21 
[1 l] which carries the lac A(I)P+O+A(Z)Y+A(A) region 
was inserted into plasmid pEMBLB( + ) [18] yielding 
plasmid pTJN2. Upon superinfection with phage IRl (a 
variant of phage Fl) cells harboring plasmid pTJN2 
produce phage particles containing single-stranded 
pTJN2 with the sense strand of the lacy gene. Localized 
mutagenesis was carried out [19] using single-stranded 
phage DNA and the synthetic oligonucleotide primer 
indicated in the figure. Transformants containing the 
mutated sequence were identified by colony hybridiza- 
tion [20] using 32P-end-labeled primer: prehybridization 
in 6 x SSC, 10 x Denhardt’s solution, 2.5 mM Na- 
EDTA, 0.5% SDS (2 h at 68°C); hybridization in the 
same solution containing “P-labeled primer (16 h at 
37°C); post-hybridization washes in 6 x SSC (30 min, 
room temperature; 30 min, 52°C; 30 min, room temper- 
ature). A hybridizing clone (pTJN2-5) was found that 
contained a new XhoII restriction site at the expected 
position corresponding to Ser’48 in the mutated Y gene 
and a second undesired X/r011 site towards the 3’-end of 
the Y gene. This latter XhoII site was eliminated by 
combining the 0.5 kb C/al-Bcfl fragment of plasmid 
pTJN2-5 with the large CluI-BclI-fragment of plasmid 
pTJN4 (a derivative of pTJN2 lacking the ClaI-site in 
the vector) yielding plasmid pJAS2. The 0.5 kb CluI- 
BctI fragment of plasmid pTJN2-5 was sequenced and 
shown to have the two expected nucleotide changes (lacy 
C 441,A441 and G443 +C443). The lacy-containing EcoRI 
fragment of pJAS2 was transferred to the vector 
pACYC184 yielding plasmid pJAS3. Transformation of 
strains T215 ([ac I+O+Z+Y-/F’IqO+Z+A(Y)) and T184 
(I+O+Z-/F’IqO+ZU’18(Y+), cf. [ll]) with pJAS3 re- 
sulted in strains T2JP and TlJP, respectively. The 
corresponding isogenous wild-type strains carrying 
plasmid pGM21 are T217 and T206. E, EcoRI; B, BclI; 
Cl, C/al; I, repressor gene of the Iac operon; PO, luc 
promoter-operator; Y, lactose carrier gene; ORI, origin 
of replication; AmpR, ampicillin resistance; Fl(IG), 
intragenic region of phage Fl. 
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tive, lactose carrier negative) background (strain 
T2JP carrying pJAS3 and strain T217 carrying 
pGM21) or a Lac Z-Y- (,&galactosidase negative, 
lactose carrier negative) background (strain Tl JP 
carrying pJAS3 and strain T206 carrying pGM21). 
3.2. Expression of the mutant lacy gene 
A recently developed immunological method 
allows the quantitation of the lactose carrier in 
cytoplasmic membranes irrespective of the func- 
tional properties of the protein [17]. Membrane 
proteins are separated by SDS-polyacrylamide gel 
electrophoresis and electrotransferred to a nitro- 
cellulose filter. The filter is treated with specific 
rabbit antibodies against the synthetic C-terminal 
decapeptide of the carrier [21] and goat anti-(rab- 
bit immunoglobulin) antibody conjugated to 
alkaline phosphatase. Using suitable chromogenic 
substrates for alkaline phosphatase, the location of 
the carrier is revealed on the filter, and the amount 
is quantitated by comparison with known amounts 
of wild-type carrier as a standard. This analysis 
shows that the mutant carrier has the same elec- 
trophoretic mobility as the wild-type protein and 
that it is incorporated into the membrane to the 
same extent (fig.2 and table 1). 
3.3. Galactoside active transport 
The mutant carrier confers a Lac+ phenotype 
upon a strain tested on lactose-containing in- 
dicator plates or mineral salts lactose plates. 
Transport data for several substrates appear in 
table 1. Lactose is transported at a maximum rate, 
V max, lo-times smaller than in the wild type while 
the half-saturation constant, KT, is increased by a 
factor of two. A decrease in Vmax and an increase 
in KT are also observed for GalSGal, NpGal and 
MeSGal. This increase in KT explains the inability 
to measure substrate binding to cytoplasmic mem- 
branes of the mutant using either NpcvGal or 
GalSGal (not shown). On the other hand, a change 
in apparent affinity is not evident for NpflGal or 
melibiose. 
Sugar: H+ stoichiometries, nn, are computed in 
mutant cells by comparison of galactoside ac- 
cumulation in the steady state (A,qactose = 102 mV, 
A,UG~ISG~I = 114 mV) with the estimated driving 
force AiH+ = - 131 mV (A$ = -88 mV; ApH = 
MEMBRANE PROTEIN [pg] 
Fig.2. Immunochemical quantitation of mutant carrier. 
Total cell envelopes were prepared from induced 
(C--O) or uninduced strain TlJP (mutant, M) and 
from induced strain T206 (wild type, M) by sonica- 
tion. Equal amounts of protein were subjected to elec- 
trophoresis in the presence of SDS, and the proteins 
were transferred to a nitrocellulose filter. The filter was 
treated with rabbit antibody directed against the synthe- 
tic carboxy terminus of the carrier and subsequently with 
goat anti-(rabbit immunoglobulin) conjugated to 
alkaline phosphatase. Carrier bands were visualized as 
described in [17], the bands were cut from the filter, and 
the phosphatase activity measured by the hydrolysis of 
1 mg/mlp-nitrophenyl phosphate (A&O). The slope for 
the samples from strain TlJP is 79.7% of that for those 
from strain T206, which contains 1.0 nmol NpcvGal 
binding sites/mg protein (cf. [9]). Membranes from 
strain TlJP contain 0.8 nmol carrier/mg protein when 
induced and only 0.05 nmol/mg when inducer is not 
present. 
-43 mV) yielding values for lactose, nH = 0.78, 
and for GalSGal, nH = 0.87. Thus, both substrates 
are actively transported with a symport stoichio- 
metry close to 1. 
3.4. Sensitivity against sulfhydryl reagents 
The activity of the wild-type carrier is inhibited 
by 0.5 mM ZV-ethylmaleimide (half-time 1.5 min, 
fig.3, M). The substrate GalSGal provides 
essentially complete protection against this in- 
hibitor (m). In contrast, the mutant carrier is 
inactivated with a half-time of =5 min (ti), 
but GalSGal affords no protection (&--+). Also, 
the mutant carrier is much less sensitive to inac- 
tivation by mercurials. When assayed by rate 
measurements of Np,&Gal hydrolysis in vivo both 
2 mM HgCL and 0.2 mM p-(chloromercuri)ben- 
zenesulfonate inactivate the wild-type protein in 
less than 5 s while the mutant is inhibited with a 
half-time of 80-90 s. 
85 
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Table 1 
Comparison of kinetic constants for mutant and wild-type lactose carrier 
Substrate Strain V nlax 
(nmol/min per (rzl) 
Concentration 
(nmol/mg 
mg protein)a protein)b 
Lactose wild type 480 0.27 
mutant 49 0.56 1.1’ 
GalSGal wild type 264 0.063 l.ld 
mutant 43 0.123 0.8’ 
NpcYGal wild type 241 0.048 0.9d 
mutant 43 0.192 0.8’ 
Np,KJal wild type 1030 0.97 
mutant 120 1.1 1.0’ 
MeSGal wild type _ 0.87’ 
mutant _ 5.1 
Melibiose wild type _ 0.5 
mutant _ 0.5 
a Measurements refer to cells. V ,,,ax was estimated either from the rate of uptake of 
radioactively labeled substrates (lactose, GalSGal, NpcuGal) or from the rate of NpPGal 
hydrolysis in vivo. KT values for MeSGal and melibiose were obtained from the 
inhibition of NpPGal hydrolysis in vivo 
b Data refer to total cell envelope protein 
’ For estimation cf. fig.2 
d Determined by substrate binding 
WILD TYPE + GALSGAL 
MUTANTI GALSGAL 
I’ a I L L I 
0 2 4 6 E 10 
TIME [mln] 
Fig.3. Inactivation of wild-type and mutant carrier by N- 
ethylmaleimide. Induced cells (400~1, A420 = 12) in 
Cohen-Rickenberg buffer [22] were treated at room tem- 
perature with N-ethylmaleimide (50/l, 5 mM) in the 
presence or absence of GalSGal (50 pl, 0.2 M) in a final 
volume of 0.5 ml. After the indicated times reactions 
were terminated by addition of 25 ,LL~ of 80 mM dithio- 
June 1985 
4. DISCUSSION 
Because site-specific mutagenesis using oligo- 
nucleotides frequently leads to undesired muta- 
tions elsewhere in the template, it is important to 
point out that restriction mapping and DNA se- 
quencing ensure that the reconstituted lacy gene in 
the mutant plasmid pJAS3 contains only the ex- 
pected base changes in codons 147 and 148 (cf. 
legend to fig.1). The mutated lacy gene is 
translated in the correct reading frame because the 
product contains the correct C-terminus. More- 
over, the mutated protein is incorporated into the 
cytoplasmic membrane of E. cofi to the same ex- 
tent as the wild-type carrier (fig.2). 
threitol. Cells were washed twice by centrifugation, re- 
suspended in buffer, and the rate of NpPGal hydrolysis 
in vivo was determined [23]. Strain T217 (wild type, 
without GalSGal, M), same plus GalSGal (O--O); 
strain T2JP (mutant with, W , or without, ti , 
GalSGal). For absolute rates cf. table 1. 
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The mutant carrier actively transports ,&galacto- 
sides with a galactoside : H+ symport stoichiometry 
close to one and confers a lactose-positive pheno- 
type on cells. Therefore, a role of this sulfhydryl 
group in the binding of the translocated proton is 
excluded. However, the maximum rate of influx 
for several substrates is reduced by a factor of 
6-10 (table 1). Within the framework of the trans- 
location cycle [4] this observation indicates that the 
translocation rate constants of the loaded or un- 
loaded carrier or both are reduced. Also, for 
several (lactose, GalSGal, NpGal, MeSGal) but 
not all substrates (NpfiGal, melibiose) the apparent 
affinity is reduced by a factor of 2-4. Finally, the 
KT for active lactose transport in the mutant is still 
much smaller (KT = 0.56 mM) than the equili- 
brium binding constant (KD = 20 mM) of the wild- 
type protein suggesting that the mutant protein still 
exhibits the AiH+-induced change in the apparent 
affinity observed for this and certain other sub- 
strates [9]. 
As expected, mutant and wild-type carrier differ 
markedly in their reactivity against sulfhydryl 
reagents. Because the mutant carrier reacts much 
more slowly with HgClz or p-(chloromercuri)ben- 
zenesulfonate than the wild type, it is clear that 
cyP* is a preferred target for these inhibitors in 
the wild-type protein. ThC rate of inactivation by 
N-ethylmaleimide is also much slower in the mu- 
tant (fig.3) whether or not saturating substrate is 
present. Unexpectedly, this rate is nevertheless 
faster than the rate of inactivation of the wild-type 
protein in the presence of the protective substrate 
GalSGal. Thus, it appears that a change in confor- 
mation caused by the mutation and reflected in 
altered values of V,,,,, and KT in the mutant makes 
a cysteinyl residue elsewhere in the protein more 
accessible to N-ethylmaleimide. This residue can 
now be identified by the methods developed in 
Beyreuther’s laboratory [5,6]. 
The mutant described by Trumble et al. [ 131 
which carries a Cy~‘~*+Gly~~~ substitution has 
properties very similar to those described for the 
mutant in this study. This mutant carrier also ac- 
tively transport lactose albeit at a reduced rate, and 
it is slowly inactivated by N-ethylmaleimide in the 
absence or presence of GalSGal. 
In summary, the data suggest hat the replace- 
ment of an SH group at position 148 by an OH 
group leaves the overall structure and function of 
the carrier unaltered but causes a subtle change in 
conformation which quantitatively alters the 
substrate affinity and the rate of translocation. 
The situation may be analogous to the behavior of 
a cysteinyl residue near the sugar binding site of 
the L-arabinose-binding protein [24,25]. In this 
protein the thiol group is not directly involved in 
sugar binding but its modification by sulfhydryl 
reagents inhibits access of the substrate to the 
binding site by steric hindrance. 
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